Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > What is everyone's Thoughts on this situation now?

<< Previous

Bullboard Posts

Next >>

Comment by Chritterson Oct 08, 2020 3:14pm

228 Views

Post# 31690246

RE:RE:RE:RE:What is everyone's Thoughts on this situation now?

I agree I think were all in the same boat, I dont know what to think, Thought this would have been unhalted by now, To much of a wait for my liking, Everyone's Money tied up over 3 months

Random1234 wrote: When this halt resumes, there will be 2 ways to go,,, if sp goies down further, I will buy further to make my avergae down,,, when it will come back to break even, I will sell,,,
or otherwise I will sell whenever it will touch my breakeven.

I found that management does not have decision making powers,, they are just trying to catch fish, if they get one ,,, they will eat first and then offer you left over. Lol..